The study, conducted by Eckehard Liske, PhD and colleagues, shows that the commercially available dose of RemiFemin Menopause, an exclusive extract of black cohosh available over-the-counter, works differently from estrogens and plant estrogens to relieve menopausal symptoms.
"This data confirms that RemiFemin provides a safe and effective option for women who want to relieve menopause symptoms naturally," said Eckehard Liske, PhD, lead author of the study. "The product reduces menopause symptoms such as hot flashes, mood swings, night sweats and occasional sleeplessness without affecting hormone levels or specific cell lines associated with some female cancers."
In addition to examining the product's lack of estrogenic effect, the study compared the effectiveness and safety of two dosage forms of RemiFemin Menopause. After six months, the currently recommended daily dose (40 mg) showed similar benefits compared to a three-fold higher dose. Specifically, the study showed that the majority of women saw a 70% reduction in their physical and emotional menopausal symptoms when they took RemiFemin twice daily for 12 weeks. The results also show that doses above 40 mg per day do not demonstrate any significant therapeutic advantages nor does the higher dose result in a significantly greater number of side effects.
"These findings add to the large body of evidence that the currently available dose of RemiFemin Menopause results in statistically significant improvements in both physical and emotional menopausal symptoms in women," said Steven Weisman, PhD, a pharmacologist and herbal expert.
Study Design and Methods
This controlled, randomized, double blind, multi-center trial
Contact: Sarah Oetgen